Approach to Collaborative Care in Bladder Cancer

"The use of telemedicine is heavily dependent on supportive legislature," write Tracey L. Krupski, MD, and Jeunice Owens-Walton, MD.

Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.

The data are to be presented at an upcoming medical conference.

In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.

The Oncologic Drugs Advisory Committee meeting is scheduled for May 21, 2025.

The sBLA for NAI was submitted to the FDA in March 2025.